News
Dan Ives has raised his price target for Palantir Technologies, signaling a 12% upside from its trading price over the next ...
Wedbush maintained its Outperform rating on Palantir Technologies (NASDAQ:PLTR) and raised the price target on the stock to $160 from $140, citing confidence in the company's AI strategy, as the ...
Investing.com -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) stock surged 22% after the company announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results